| Research cohort database (n = 559) | Routine clinic database (n = 559) | Routine clinic database (n = 1233) | % underreporting of OI events in 559 patients in routine clinic vs. research cohort database (Comparison A) | % underreporting of OI events in 1233 patients in routine clinic vs. research cohort database (Comparison B) | ||||
---|---|---|---|---|---|---|---|---|---|
Type of OI | No. of OI events | Incidence rate (95% CI (per 100 PYAR) | No. of OI events | Incidence rate (95% CI (per 100 PYAR) | No. of OI events | Incidence rate (95% CI (per 100 PYAR) | Based on absolute number of OI events | Based on OI rates | Based on OI rates |
Overall (initial OI only) | 154a | 24.1 (20.5- 28.2) | 91a | 13.2 (10.8 - 16.2) | 206a | 10.4 (9.1 - 11.9) | 40.9 | 45.2 | 56.8 |
Oral candidiasis | 63 | 8.4 (6.5 - 10.7) | 26 | 3.7 (2.5 - 5.4) | 54 | 2.6 (2.0 - 3.3) | 58.7 | 55.9 | 69.0 |
Severe bacterial pneumonia | 44 | 5.5 (4.1 - 7.6) | 8 | 1.0 (0.5 - 2.1) | 4 | 0.2 (0.1 - 0.5) | 81.8 | 81.8 | 96.4 |
Tuberculosis | 33 | 4.1 (2.9 - 5.8) | 27 | 3.6 (2.5 - 5.3) | 73 | 3.6 (2.8 - 4.5) | 18.2 | 12.2 | 12.2 |
Herpes zoster | 29 | 3.6 (2.5 - 5.2) | 5 | 0.6 (0.3 - 1.3) | 9 | 0.4 (0.2 - 0.8) | 82.7 | 83.3 | 88.8 |
Cryptococcus meningitis | 7 | 0.8 (0.4 - 1.8) | 7 | 0.9 (0.4 - 1.9) | 16 | 0.7 (0.4 - 1.2) | 0 | +12.5 b | 12.5 |
Genital herpes | 5 | 0.6 (0.2 - 1.4) | 15 | 2.0 (1.2 - 3.3) | 12 | 0.5 (0.3 - 1.0) | +200 b | +233b | 16.7 |
Kaposi's sarcoma | 5 | 0.6 (0.2 - 1.4) | 5 | 0.6 (0.3 - 1.6) | 31 | 1.5 (1.1 - 2.2) | 0 | +16.7 b | +150 b |
Oesophageal candidiasis | 5 | 0.6 (0.2 - 1.4) | 0 | 0.0 (0.0 - 0.0) | 4 | 0.2 (0.1 - 0.5) | 100 | 100 | 66.7 |
Cerebral toxoplasmosis | 2 | 0.2 (0.1 - 0.9) | 0 | 0.0 (0.0 - 0.0) | 4 | 0.2 (0.1 - 0.5) | 100 | 100 | 0 |
Other OIsc | 8 | 0.9 (0.5 - 1.9) | 3 | 0.4 (0.1 - 1.2) | 11 | 0.5 (0.3 - 0.9) | 62.5 | 55.5 | 44.4 |